Jove
Visualize
Contact Us

Related Experiment Videos

Current issues in German healthcare.

J M Graf von der Schulenburg1, A Uber

  • 1Institute for Insurance Economics, University of Hannover, Germany.

Pharmacoeconomics
|October 4, 1997
PubMed
Summary

Germany's social health insurance system features compulsory membership and income-dependent contributions. Recent reforms include market competition and fixed budgets to contain healthcare costs, particularly for pharmaceuticals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis.

Tobacco induced diseases·2016
Same author

Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country.

The European journal of health economics : HEPAC : health economics in prevention and care·2015
Same author

Cost of poor adherence to anti-hypertensive therapy in five European countries.

The European journal of health economics : HEPAC : health economics in prevention and care·2014
Same author

[Implementation of the new German job role code and its application in claims data analysis. Possibilities and limitations].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2012
Same author

Measuring the unmeasurable: the role and importance of quality of life measurement in economic evaluations of sleep disorder treatment.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

Muscle precursor cells in the developing limbs of two isopods (Crustacea, Peracarida): an immunohistochemical study using a novel monoclonal antibody against myosin heavy chain.

Development genes and evolution·2008
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Health economics
  • Public health policy
  • Healthcare systems analysis

Background:

  • Germany employs a social health insurance model characterized by compulsory membership, income-based contributions, comprehensive benefits, and public regulation.
  • The system is administered by non-profit "sickness funds" operating under public law.

Purpose of the Study:

  • To analyze the German healthcare system, its reform history, and current legislation.
  • To examine the German pharmaceutical market, its regulation, and cost-containment strategies.

Main Methods:

  • Analysis of historical healthcare reforms in Germany since the mid-1970s.
  • Review of current German healthcare acts and policy developments.
  • Examination of pharmaceutical pricing and cost-containment measures, including global budgets and copayments.

Main Results:

  • Germany has implemented significant healthcare reforms, including the introduction of market competition in health insurance and fixed budgets.
  • Cost-containment policies for pharmaceuticals are a key focus, with specific measures like global budgets for medicines and patient copayments in place.

Conclusions:

  • The German social health insurance model has undergone substantial reforms to address rising healthcare costs.
  • Market competition and fixed budgeting are current policy tools shaping the German healthcare landscape, especially within the pharmaceutical sector.

Related Experiment Videos